Xeloda and Hypercalcaemia - a phase IV clinical study of FDA data
Hypercalcaemia is found among people who take Xeloda, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Xeloda and have Hypercalcaemia. It is created by eHealthMe based on reports of 44,763 people who have side effects when taking Xeloda from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
44,763 people reported to have side effects when taking Xeloda.
Among them, 116 people (0.26%) have Hypercalcaemia.
What is Xeloda?
Xeloda has active ingredients of capecitabine. It is often used in colon cancer. eHealthMe is studying from 45,113 Xeloda users for its effectiveness, alternative drugs and more.
What is Hypercalcaemia?
Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,572 drugs and 964 conditions by eHealthMe.
Number of Xeloda and Hypercalcaemia reports submitted per year:
Time on Xeloda when people have Hypercalcaemia *:
Gender of people who have Hypercalcaemia when taking Xeloda*:
Age of people who have Hypercalcaemia when taking Xeloda *:
Common drugs people take besides Xeloda *:
Common side effects people have besides Hypercalcaemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xeloda and have Hypercalcaemia?Check whether Hypercalcaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
How severe was Hypercalcaemia and when was it recovered:
Expand to all the drugs that have ingredients of capecitabine:
Alternative drugs to, pros and cons of Xeloda:
- Xeloda (45,113 reports)
Common Xeloda side effects:
Browse all side effects of Xeloda:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hypercalcaemia treatments and more:
- Hypercalcaemia (16,400 reports)
COVID vaccines that are related to Hypercalcaemia:
- Hypercalcaemia in Moderna COVID Vaccine
- Hypercalcaemia in Pfizer BioNTech Covid Vaccine
- Hypercalcaemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypercalcaemia:
All the drugs that are associated with Hypercalcaemia:
- Hypercalcaemia (1,572 drugs)
Common conditions associated with Hypercalcaemia:
All the conditions that are associated with Hypercalcaemia:
- Hypercalcaemia (964 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on capecitabine (the active ingredients of Xeloda) and Xeloda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tazidime and Norethindrone drug interaction - 5 seconds ago
- Drug Abuse And Dependence and Pressure Ulcer - 19 seconds ago
- Dicyclomine Hydrochloride and Scleritis - 31 seconds ago
- Protonix and Tic - 35 seconds ago
- Pacerone and Migraine Aggravated - 43 seconds ago
- Hydrocortone vs. Oxycet - 53 seconds ago
- Nosebleed and drugs of ingredients of memantine hydrochloride - a minute ago
- All-Trans Retinoic Acid and Arrhythmias - a minute ago
- Candesartan Cilexetil and Cannabis drug interaction - a minute ago
- Dtic-Dome and Pulmonary Embolism - a minute ago